HBK Investments’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,079
Closed -$378K 450
2022
Q2
$378K Sell
4,079
-49,358
-92% -$4.82M ﹤0.01% 458
2022
Q1
$5.41M Buy
+53,437
New +$5.61M 0.02% 240
2021
Q3
Sell
-9,414
Closed -$789K 784
2021
Q2
$786K Buy
+9,414
New +$771K ﹤0.01% 602
2021
Q1
Sell
-117,500
Closed -$8.03M 888
2020
Q4
$8.03M Sell
117,500
-25,625
-18% -$1.67M 0.05% 161
2020
Q3
$8.36M Buy
143,125
+62,904
+78% +$3.91M 0.06% 133
2020
Q2
$5.21M Buy
+80,221
New +$5.05M 0.07% 186
2019
Q3
Sell
-14,600
Closed -$865K 663
2019
Q2
$796K Buy
+14,600
New +$786K 0.01% 456
2019
Q1
Sell
-91,383
Closed -$5.99M 1112
2018
Q4
$5.99M Buy
+91,383
New +$6.82M 0.06% 240
2017
Q2
Sell
-10,568
Closed -$830K 932
2017
Q1
$830K Buy
+10,568
New +$844K 0.01% 443
2016
Q4
Sell
-14,025
Closed -$1.25M 754
2016
Q3
$1.25M Buy
14,025
+9,496
+210% +$896K 0.01% 467
2016
Q2
$434K Buy
+4,529
New +$451K ﹤0.01% 774
2013
Q4
Sell
-15,000
Closed -$851K 914
2013
Q3
$851K Buy
+15,000
New +$894K 0.01% 495

Other funds holding CVS

HBK Investments's CVS Position: Q3 2022 in Review

HBK Investments sold out of CVS Health (CVS) in Q3 2022, closing a stake of 4,079 shares — an estimated $378K sold.

HBK Investments first reported a position in CVS in Q3 2013 and held it in 12 quarters. The position peaked at $8.36M in Q3 2020. 2,324 funds tracked by Wall St. Rank hold CVS as of Q3 2022.

  • HBK Investments reported no remaining CVS Health position as of Q3 2022 after selling out during the quarter.
  • HBK Investments sold 4,079 CVS Health shares in Q3 2022, an estimated $378K.
  • HBK Investments first reported a position in CVS Health in Q3 2013 and held it in 12 quarters.
  • HBK Investments's CVS Health position peaked at $8.36M in Q3 2020.
  • 2,324 funds tracked by Wall St. Rank held CVS Health as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.